Literature DB >> 1845919

Role of oxygen free radicals in ischemic and reperfused myocardium.

R Ferrari1, C Ceconi, S Curello, A Cargnoni, E Pasini, F De Giuli, A Albertini.   

Abstract

In recent years there has been considerable interest concerning the role of oxygen radicals in myocardial ischemia and reperfusion injury. The sequential univalent reduction of oxygen gives rise to very reactive intermediate products. Normally, the tissue concentration of these intermediate products of oxygen is limited and the aerobic myocardium survives because of the existence of a delicate balance between the generation of the various oxidants and the maintenance of the antioxidant defense mechanism. Several possible sources have been identified for the production of active oxygen species after ischemia and reperfusion and these sources may be mutually interactive. The ability of scavengers of oxygen free radicals, including vitamin E, to improve mechanical, mitochondrial, and sarcoplasmic reticulum function in animal models of ischemic-reperfusion injury also suggests that oxygen free radicals are partly responsible for myocardial damage in these models, although caution in the interpretation of these data is necessary.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845919     DOI: 10.1093/ajcn/53.1.215S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  14 in total

1.  The protective effect of desferal on rat myocardial mitochondria is not prolonged after withdrawal of desferal.

Authors:  H van Jaarsveld; J M Kuyl; D W Alberts
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

2.  Impairment of pH gradient and membrane potential mediates redox dysfunction in the mitochondria of the post-ischemic heart.

Authors:  Patrick T Kang; Chwen-Lih Chen; Paul Lin; William M Chilian; Yeong-Renn Chen
Journal:  Basic Res Cardiol       Date:  2017-05-16       Impact factor: 17.165

3.  Biphasic modulation of the mitochondrial electron transport chain in myocardial ischemia and reperfusion.

Authors:  Hsin-Ling Lee; Chwen-Lih Chen; Steve T Yeh; Jay L Zweier; Yeong-Renn Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-20       Impact factor: 4.733

Review 4.  Mitochondrial energy production and cation control in myocardial ischaemia and reperfusion.

Authors:  R Ferrari; P Pedersini; M Bongrazio; G Gaia; P Bernocchi; F Di Lisa; O Visioli
Journal:  Basic Res Cardiol       Date:  1993 Sep-Oct       Impact factor: 17.165

5.  [Effect of administration of selenium and vitamin E on heart failure and ventricular arrhythmias in patients with acute myocardial infarct].

Authors:  P Tränkmann; R Thiele; K Winnefeld; K Seliger
Journal:  Med Klin (Munich)       Date:  1999-10-15

6.  Role of timing of administration in the cardioprotective effect of fructose-1,6-bisphosphate.

Authors:  A Cargnoni; E Condorelli; A Boraso; L Comini; F De Giuli; E Pasini; R Ferrari
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 7.  Cardiac mitochondria and reactive oxygen species generation.

Authors:  Yeong-Renn Chen; Jay L Zweier
Journal:  Circ Res       Date:  2014-01-31       Impact factor: 17.367

8.  Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial complex II in the post-ischemic myocardium.

Authors:  Chwen-Lih Chen; Jingfeng Chen; Sharad Rawale; Saradhadevi Varadharaj; Pravin P T Kaumaya; Jay L Zweier; Yeong-Renn Chen
Journal:  J Biol Chem       Date:  2008-08-05       Impact factor: 5.157

9.  Essential fatty acids alter the activity of manganese-superoxide dismutase in rat heart.

Authors:  A C Phylactos; L S Harbige; M A Crawford
Journal:  Lipids       Date:  1994-02       Impact factor: 1.880

10.  Ibuprofen abolishes the increase in leucocyte chemiluminescence observed during ischemic myocardial failure, but fails to improve hemodynamic function.

Authors:  K Ytrehus; A G Semb; E S Myhre
Journal:  Basic Res Cardiol       Date:  1992 Jul-Aug       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.